整合多omics数据和机器学习来识别1型糖尿病中的抗氧化生物标志物
Junming Luo1, Xin Guo2, Yijing Zheng2
1Department of Respiratory Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, P. R. China.
Free radical biology & medicine
|May 8, 2025
概括
研究人员在血清中确定了1型糖尿病 (T1DM) 诊断的关键抗氧化蛋白. GPX3显示出高诊断价值,并保护免受氧化损伤,为T1DM进展提供了潜在的生物标志物.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 第1型糖尿病 (T1DM) 管理需要可靠的生物标志物用于早期诊断和进展监测.
- 氧化应激在T1DM病变发生过程中起着重要作用.
研究的目的:
- 通过使用多omics数据和机器学习,识别新型血清抗氧化应激蛋白作为T1DM的潜在生物标志物.
- 评估T1DM中已识别的生物标志物的诊断和预后价值.
主要方法:
- 集成的多omics数据分析,包括对老鼠和人类转录组数据的权重基因共同表达网络分析 (WGCNA).
- 来自T1DM患者和健康对照的血清样本的蛋白质组分析 (LC-MS/MS).
- 机器学习算法 (随机森林,SVM-RFE) 用于生物标志物的识别和验证.
主要成果:
- 确定了33种在氧化应激通路中富含的差异表达蛋白质.
- 通过机器学习算法选择了五种关键蛋白质 (GPX3,GSTP1,PRDX6,SOD1,MSRB2).
- GPX3具有显著的诊断价值,与HbA1c和空腹血葡萄糖相关,并保护胰腺β细胞免受体外和体内氧化损伤.
结论:
- GPX3是一种有前途的血清生物标志物,用于早期诊断和监测1型糖尿病的进展.
- 针对氧化应激路径,特别是涉及GPX3,可能为T1DM提供新的治疗策略.
更多相关视频
09:47Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
907
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
1.0K
相关概念视频
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.